Search

中文 / English

Address: No. 35, Simiao Road, Daxing Biomedical Industrial Base, Zhongguancun Science Park, Daxing District, Beijing
 Copyright: Beijing Minhai Biological Technology Co., Ltd.   
Beijing ICP 10007676    Powered by  www.300.cn Beijing    Beijing Public Security No. 110115000037 Internet Drug Information Service Qualification Certificate (Beijing) Non-operating 20150173

Contact

Administrative Office: 010-59613600
Supplier consultation: 010-59613585
Recruitment: 010-59613633
Marketing: 010-59613639
Medical support: 010-59613669

Links:

>
>
>
Beijing Minhai Biotechnology Co., Ltd. R & D and production building construction project (third floor) first environmental impact assessment information disclosure

Beijing Minhai Biotechnology Co., Ltd. R & D and production building construction project (third floor) first environmental impact assessment information disclosure

Release time:
2019/04/26
Page view
(1) Construction project name: Beijing Minhai Biological Technology Co., Ltd. R & D and production building construction project (third floor)
 
(2) Site selection: The reserved workshop on the third floor of the R & D and production building of Beijing Minhai Biotechnology Co., Ltd., Daxing Biomedical Industrial Base, Zhongguancun Science and Technology Park, Daxing District, Beijing.
 
The overview of the existing projects and environmental protection of Beijing Minhai Biotechnology Co., Ltd. are shown in the table below.
 
Overview of existing projects and implementation of environmental protection procedures

 

Number

project name

Main construction content

Approval number

Approval category

Completed environmental protection acceptance

1

Daxing Production Base Project of Beijing Minhai Biotechnology Co., Ltd.

It covers an area of 80889.6m2, and has an office R & D building, a cell-free H. influenzae type b combined vaccine production plant, a japonic chickenpox production plant, an animal room, a dangerous goods store, a canteen, an integrated sewage treatment station

Beijing Central Audit [2007] No. 777

report

Passed the acceptance in December 2011 and approved the document number Jinghuan inspection [2011] No.284

2

Minhai Biological Industrialization Project of "Human Diploid Cell Rabies Vaccine"

Annual output of 5 million (one million copies) human diploid cell rabies vaccine freeze-dried powder injection

Jingxing Environmental Review [2012] No. 0212

report

Passed the acceptance in March 2016, and approved the document number Jingxing Huanyan [2016] No. 36

3

23-valent pneumococcal polysaccharide vaccine industrialization project

Annual production of 10 million 23-valent pneumococcal polysaccharide vaccines

Jingxing Environmental Review [2012] No. 0171

report

Passed the acceptance in May 2016 and approved the document number Jingxing Huanyan [2016] No. 78

4

Construction of a pilot platform for biological vaccines

Annual production of 100,000 three-component pertussis vaccines (100,000 people), 15-valent pneumococcal conjugate vaccine 400,000 (100,000 people), ACYW135 meningococcal conjugate vaccine 300,000 (100,000 people), 5 100,000 rotavirus vaccines (100,000 copies), human diploid cell rabies vaccine freeze-dried powder injections 500,000 pieces / year (100,000 copies)

Jingxing Environmental Audit [2012] No. 0251

report

Cancel construction

5

Pre-filled vaccine workshop construction project

Annual production of 36 million pre-filled vaccines

Jingxing Environmental Review [2013] No. 2

report

2016年3月已通过验收,审批文号京兴环验[2016]32号

6

New vaccines Beijing engineering laboratory innovation capacity building project

Engineering laboratory with 4 platforms: protein-bound vaccine platform, multi-link multivalent vaccine platform, oral vaccine platform and vaccine quality evaluation platform

Jingxing Environmental Review [2012] No. 0288

report

Environmental protection acceptance is being commissioned

7

Pre-filling filling workshop construction project

36 million pre-filled filling workshops

Jingxing Environmental Audit
[2014] No. 220

report

Address change environmental assessment has been approved, Jingxing Environmental Review [2019] No. 17

8

Beijing Minhai Biological Technology Co., Ltd. R & D and production building construction project

Sub-packaging workshop, finished product cold storage, pure water station, etc. The production workshop includes one 15 million dose / year rabies vaccine (lyophilized) and one 20 million dose / year sIPV vaccine (liquid) production line;

Beijing Central Audit
[2016] No. 203

report

The acceptance conditions have not been met

9

Construction project of Minhai Biological New Vaccine International Industrial Base (Phase I)

It covers a total area of 90013.218m2, newly built production workshops, R & D buildings, sub-packaging storage buildings, animal houses, sewage treatment stations and supporting ancillary facilities, hazardous waste and dangerous goods warehouses, canteens and comprehensive service buildings, etc., with a total construction area of 149320m2. Annual production of 25 million doses of pneumococcal conjugate vaccine; 20 million doses of adsorbed cell-free leukoderma + inactivated poliomyelitis + Haemophilus influenzae type b five-pump vaccine; Mabella varicella series vaccine: Mabira combined attenuated live 20 million doses of vaccine, 5 million doses of live attenuated varicella varicella combined vaccine and 10 million doses of lyophilized live attenuated varicella vaccine.

Beijing Central Audit
[2019] No. 53

report

/

 
(4) Name of construction unit: Beijing Minhai Biological Technology Co., Ltd.
 
Contact: Xia Zhanxiong
 
Telephone: 010-59613634
 
Email: xiazhanxiong@biominhai.com
 
(5) Compiling unit of environmental impact report: Beijing Zhonghuan Bohong Environmental Resources Technology Co., Ltd.
 
(6) Web link to the public comment form: http://www.biominhai.com/xwzx_xi/newsId=363.html
 
(7) Ways and means of submitting public comment forms.
 
Phone: 010-59613634
 
Email: xiazhanxiong@biominhai.com
 
In the process of preparing the draft of the environmental impact report, the public can submit opinions related to the environmental impact assessment to the construction unit.